lansoprazole has been researched along with pentagastrin in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Inatomi, N; Nagaya, H; Satoh, H | 1 |
| Dammann, HG; Leucht, U; Müller, P; Simon, B | 1 |
| Hirschowitz, BI; Mohnen, J; Shaw, S | 1 |
| Fuchs, W; Göksu, MA; Müller, P; Schlüter, F; Simon, B | 1 |
| Bell, N; Greski-Rose, P; Hunt, RH; Jennings, DE; Karol, MD; Sachs, G | 1 |
| Fossmark, R; Johanessen, E; Johnsen, G; Waldum, HL | 1 |
1 review(s) available for lansoprazole and pentagastrin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 trial(s) available for lansoprazole and pentagastrin
| Article | Year |
|---|---|
Long-term treatment with lansoprazole for patients with Zollinger-Ellison syndrome.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Enzyme Inhibitors; Female; Gastric Acid; Gastric Mucosa; Gastrins; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Patient Dropouts; Pentagastrin; Proton Pump Inhibitors; Zollinger-Ellison Syndrome | 1996 |
Initial potency of lansoprazole and omeprazole tablets on pentagastrin-stimulated gastric acid secretion-a placebo-controlled study in healthy volunteers.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Gastric Acid; Gastric Mucosa; Humans; Lansoprazole; Male; Omeprazole; Pentagastrin; Proton Pump Inhibitors; Tablets | 2000 |
Duration of effect of lansoprazole on gastric pH and acid secretion in normal male volunteers.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Double-Blind Method; Enzyme Inhibitors; Gastric Acid; Gastric Acidity Determination; Gastric Mucosa; Gastrins; Humans; Lansoprazole; Male; Omeprazole; Pentagastrin; Time Factors | 2001 |
4 other study(ies) available for lansoprazole and pentagastrin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Differences in the antisecretory actions of the proton pump inhibitor AG-1749 (lansoprazole) and the histamine H2-receptor antagonist famotidine in rats and dogs.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Bethanechol Compounds; Dogs; Famotidine; Female; Gastric Acid; Gastric Mucosa; Histamine; Hydrogen-Ion Concentration; Lansoprazole; Male; Omeprazole; Pentagastrin; Peptones; Pylorus; Rats; Rats, Inbred Strains | 1991 |
Human gastric acid secretion following repeated doses of AG-1749.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Gastric Acid; Humans; Hydrogen-Ion Concentration; Lansoprazole; Male; Omeprazole; Pentagastrin | 1989 |
Rebound acid hypersecretion after long-term inhibition of gastric acid secretion.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Antacids; Anti-Ulcer Agents; Enterochromaffin-like Cells; Esophagitis; Female; Gastric Acid; Gastroesophageal Reflux; Humans; Immunohistochemistry; Lansoprazole; Long-Term Care; Male; Middle Aged; Omeprazole; Pentagastrin; Proton Pump Inhibitors | 2005 |